Publications

Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer’s Disease

Lord, J., Jermy, B., Green, R., Wong, A., Xu, J., Legido-Quigley, C., … & Proitsi, P. (2021). Proceedings of the National Academy of Sciences, 118(16).

A genome-wide association study of plasma phosphorylated tau181

Lord, J., Zettergren, A., Ashton, N., Karikari, T.K., N. J., Benedet, Simren, J., … & Proitsi, P. (2021). Neurobiology of Aging.

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

Zettergren, A., Lord, J., Ashton, N. J., Benedet, A. L., Karikari, T. K., Rodriguez, J. L., … & Blennow, K. (2021). Alzheimer’s Research & Therapy, 13(1), 1-10.

Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease

Xu, J., Bankov, G., Kim, M., Wretlind, A., Lord, J., Green, R., … & Legido-Quigley, C. (2020). Translational Neurodegeneration. 9(1), 1-15


Open Access Pre-prints

Assessing genetic overlap and causality between blood plasma proteins and Alzheimer’s Disease

Handy, A., Lord, J., Green, R., Xu, J., Aarsland, D., Velayudhan, L., … & GERAD1 Consortium. (2021)

Deciphering the causal relationship between blood metabolites and Alzheimers Disease: a Mendelian Randomization study

Lord, J., Jermy, B., Green, R., Wong, A., Xu, J., Legido-Quigley, C., … & Proitsi, P. (2020)

Metabolic correlates of late midlife cognitive function: findings from the 1946 British Birth Cohort

Green, B., Lord, J., Xu, J., Maddock, J., Kim, M., Dobson, R., … & Proitsi, P. (2020)